AI/ML Innovations Inc.

The Issuer is a digital health solutions provider utilizing a proprietary combination of digital health monitoring devices, AI based software, and a cloud computing platform which combine to help care givers, patients and healthcare professionals access and utilize relevant health data.


NeonMind Biosciences Inc.

The Issuer is engaged in preclinical research to develop potential clinical treatments and wellness products to address obesity and weight management conditions and to promote health and wellness. The Issuer operates three divisions: (i) a pharmaceutical division engaged in drug development of psychedelic compounds with two lead psilocybin-based drug candidates targeting obesity; and (ii) a medical services division focused on launching specialty mental health clinics that integrate psychedelic therapeutics into traditional psychotherapy settings. 


Myconic Capital Corp.

Myconic Capital Corp.est un émetteur d'investissement doté d'un portefeuille diversifié axé sur les sociétés émergentes actives dans les secteurs de la haute technologie, de l'immobilier, du cannabis, des mines et de la santé et du bien-être.


79 Resources Ltd.

The Company is engaged in the business of mineral exploration and the acquisition of mineral property assets in Canada. The company holds the Five Point Gold Property, a district-scale exploration project covering nearly 120,000 hectares in central British Columbia within the Nechako Plateau.